Health Care/Hospital
I-Mab Announces Upcoming Participation at November Conferences
SHANGHAI and GAITHERSBURG, Md., Nov. 3, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences in Novemb...
2021-11-03 20:00
1387
BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia
SHENZHEN, China, Nov. 3, 2021 /PRNewswire/ -- As reported by Indonesian National Agency of Drug and Food Control (BPOM), BPOM grants the Emergency Use Authorization (EUA) for COVID-19 Vaccine (ChAdOx1-S[recombinant])/KconecaVac manufactured by Shenzhen Kangtai Biological Products Co., Ltd. It is ...
2021-11-03 19:02
1609
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021
DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldor...
2021-11-03 15:00
1778
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join
LONDON, Nov. 3, 2021 /PRNewswire/ -- In his recent opening address to the G20, Italian Prime MinisterMario Draghi highlighted vaccine inequity, emphasizing the fact that only 3% of eligible people living in the world's poorest nations had received any form of COVID-19 vaccine, versus more than 70...
2021-11-03 12:28
1511
Kintor Pharma Doses First Patient in Clinical Trial of ALK-1 in Combination with KN046 In Advanced or Refractory Solid Tumors
SUZHOU, China, Nov. 3, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company has enrolled and dosed its first patient with advanced...
2021-11-03 08:32
1975
Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters
* Advancement of Nabota and prescriptions... KRW 290.6B sales and KRW 22.7B operating income * Expanding growth momentum with the release of Fexuprazan in Korea and Nabota inEurope next year SEOUL, South Korea, Nov. 2, 2021 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) (CEOSengho Jeon) a...
2021-11-02 21:00
1539
GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center
PISCATAWAY, New Jersey, Nov. 2, 2021 /PRNewswire/ -- GenScript USA Inc
2021-11-02 19:30
1874
PD-1/VEGF Bi-Specific Antibody (AK112) Obtained Approval to Initiate a Phase II Clinical Trial for Monotherapy or Combined Chemotherapy Neoadjuvant/Adjuvant Therapy of Resectable Non-Small Cell Lung Cancer
HONG KONG, Nov. 2, 2021 /PRNewswire/ -- Akeso, Inc. (the Company, 9926.HK) announces that AK112 (PD-1/VEGF bi-specific antibody), the novel immuno-oncology drug independently developed by the Company, obtained approval from the Center for Drug Evaluation (CDE) of the National Medical Products Ad...
2021-11-02 11:53
1722
New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA
TAIPEI, Nov. 1, 2021 /PRNewswire/ -- TCI Co., Ltd. has long been engaged in the research and development of banana peels and banana stamens, and finally passed the US FDA NDI approval in the middle of this year, becoming the world's first bananaNDI. It is an important milestone for Taiwan's banan...
2021-11-02 09:00
1456
111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to Follow
SHANGHAI, Oct. 28, 2021 /PRNewswire/ – 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results ...
2021-11-02 04:57
2393
Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 Epidemic
JIUQUAN, China, Nov. 1, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that recently, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. ("Gansu QLS"), the Comp...
2021-11-01 20:00
1367
I-Mab Strengthens Senior Executive Team with New Chief Financial Officer and Chief Strategy Officer Appointments
SHANGHAI and GAITHERSBURG, Md., Nov. 1, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced the appointment ofJohn Long as the Company's Chief Finan...
2021-11-01 20:00
1507
Empowering Patients To Manage Their Chronic Conditions With The Establishment Of The Scientific Advisory Board By Healint
SINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Healint has announced the establishment of their Scientific Advisory Board (SAB) comprising an international team of clinician-scientists who are recognised for their achievements in the fields of chronic central nervous system (CNS) and autoimmune conditio...
2021-11-01 19:15
1385
Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2 Social Anxiety Disorder PREVAIL Study
* U.S. FDA clearance of IND for BNC210 evaluation as an acute treatment for patients with Social Anxiety Disorder in a Phase 2 clinical trial, the PREVAIL Study * The PREVAIL Study remains on target to initiate by end of 2021 and is expected to read out topline data by end of 2022 ADELAIDE, A...
2021-11-01 18:00
2223
Achedaway releases a cupping therapy game-changer: Achedaway Cupper
LOS ANGELES, Nov. 1, 2021 /PRNewswire/ -- Achedaway, a technology company that develops products for fitness, rehabilitation and therapy, has expanded its product portfolio to the industry of cupping therapy, aiming to allow people to get cupping therapy at home for pain relief without visiting a...
2021-11-01 14:17
1504
HOPSTEM completed 40 million USD series B financing, to develop safe, effective and affordable iPSC cell therapies for global patients
CAYMAN ISLANDS, British Overseas Territory, Oct. 31, 2021 /PRNewswire/ -- After A++ financing in May this year, HOPSTEM announced that the company has completed a round of near40 million USD Series B financing, led by a top VC/PE in biomedical field, followed by Lilly Asia Ventures and current sh...
2021-11-01 08:00
1110
Invetech Named Victorian Top Exporter of the Year
MELBOURNE, Australia, Oct. 30, 2021 /PRNewswire/ -- Invetech, an end-to-end commercialisation partner to world's foremost therapeutic and diagnostic companies, has been named the Victorian Exporter of the Year at the2021 Governor of Victoria Export Awards (GOVEA). Invetech also won the Internatio...
2021-10-30 05:35
3681
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval inAustralia -- In addition to today's submission to the Therapeutic Goods Administration, the company recently filed for authorization with MHRA, with additional filings in...
2021-10-29 19:15
5850
Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment
SHANGHAI, Oct. 29, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management ...
2021-10-29 18:30
1700
China's New Regulation on Internet Healthcare will Benefit Platforms like WeDoctor
HANGZHOU, China, Oct. 29, 2021 /PRNewswire/ -- On 27 October, China's National Health Commission (NHC), the authority responsible for the medical industry, issued a new policy that calls for the regulation ofChina's fast-growing Internet healthcare industry. The policy is expected to pushChina's ...
2021-10-29 17:41
1324
Week's Top Stories
Most Reposted
2024 Malaysia E-Commerce Product Selection Expo Attracts International Delegations
[Picked up by 313 media titles]
2024-12-02 12:06
ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 298 media titles]
2024-11-28 17:24AC Health makes critical HIV care more accessible to Filipinos with USAID support
[Picked up by 298 media titles]
2024-12-03 16:11
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 288 media titles]
2024-11-29 20:33
Hong Kong Airlines Resumes Vancouver Service Offering Twice-weekly direct flights from 18 January 2025
[Picked up by 287 media titles]
2024-12-02 20:01
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
9953
China's spicy hotpot sets its sights on global market
2024-11-29 21:36
4334
CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China
2024-11-30 09:00
4310